Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWolf Minerals Regulatory News (WLFE)

  • There is currently no data for WLFE

Exercise of Options

4 Oct 2012 07:00

RNS Number : 8664N
Wolf Minerals Limited
04 October 2012
 



4 October 2012

Wolf Minerals

 

Exercise of Options

 

 

Specialty metal exploration and development company Wolf Minerals Limited (ASX: WLF) (AIM: WLFE) ("Wolf" or the "Company") has applied for 2,815,380 depository interests representing fully paid ordinary shares (the "Shares") to be admitted to trading on the AIM market of the London Stock Exchange ('AIM') ("Admission").

The Shares are being issued pursuant to an exercise of options. Of the 2,815,380 options being exercised 85,000 are being exercised by Directors of the Company, namely John Hopkins and Humphrey Hale. Further details are set out below:

Director

Number of options exercised

Exercise Price

Total number of ordinary shares held following exercise of options

Percentage of enlarged issued share capital

John Hopkins

34,000

A$0.235

204,000

0.18%

Humphrey Hale

51,000

A$0.235

2,006,000

1.77%

Also, the following options expired on 30 September 2012:

• 13,833,654 listed options with an exercise price of A$0.235.

• 850,000 unlisted options with an exercise price of A$0.295.

Following Admission of the Shares, the number of Ordinary Shares in issue and admitted to trading on AIM and the ASX will be 113,503,293 and the number of options admitted to trading on the ASX will be nil.

For further details, please contact:

Wolf Minerals Limited

Humphrey Hale

+61 8 6364 3776

Investec

Chris Sim/Neil Elliot

+44 (0) 20 7597 5970

 

Newgate Threadneedle

Beth Harris/Josh Royston

+44 (0) 20 7653 9850

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBSBDGRDGBGDX
Date   Source Headline
30th Jan 20187:00 amRNSAppendix 5B
30th Jan 20187:00 amRNSQuarterly Activities Report
4th Jan 20184:40 pmRNSSecond Price Monitoring Extn
4th Jan 20184:35 pmRNSPrice Monitoring Extension
27th Dec 20177:35 amRNSDirector/PDMR Shareholding
27th Dec 20177:35 amRNSDirector/PDMR Shareholding
27th Dec 20177:34 amRNSDirector/PDMR Shareholding
27th Dec 20177:34 amRNSDirector/PDMR Shareholding
27th Dec 20177:34 amRNSAppendix 3Y
27th Dec 20177:34 amRNSAppendix 3Y
27th Dec 20177:33 amRNSAppendix 3Y
27th Dec 20177:33 amRNSAppendix 3Y
27th Dec 20177:33 amRNSAppendix 3B
27th Dec 20177:32 amRNSCleansing Notice Letter
27th Dec 20177:32 amRNSIssue of Equity and Change of Directors' Interests
12th Dec 20178:32 amRNSDirector/PDMR Shareholding
12th Dec 20178:32 amRNSDirector/PDMR Shareholding
12th Dec 20178:32 amRNSDirector/PDMR Shareholding
12th Dec 20178:32 amRNSDirector/PDMR Shareholding
12th Dec 20178:32 amRNSDirector/PDMR Shareholding
12th Dec 20178:31 amRNSAppendix 3Y
12th Dec 20178:31 amRNSAppendix 3Y
12th Dec 20178:31 amRNSAppendix 3Y
12th Dec 20178:31 amRNSAppendix 3Y
12th Dec 20178:31 amRNSAppendix 3Y
12th Dec 20178:31 amRNSAppendix 3B
12th Dec 20178:30 amRNSCleansing Notice Letter
12th Dec 20178:30 amRNSIssue of Equity and Change of Directors' Interests
28th Nov 20177:00 amRNSResult of AGM
31st Oct 20177:01 amRNSAppendix 5B
31st Oct 20177:00 amRNSQuarterly Activities Report
30th Oct 20177:00 amRNSGrant of ASX Rule Waiver for Bridge Facility
27th Oct 20173:52 pmRNSAdditional £10 Million Funding
20th Oct 20177:00 amRNSNotice of Annual General Meeting
2nd Oct 20177:00 amRNSReplacement Annual Report
29th Sep 20177:05 amRNSCorporate Governance Statement
29th Sep 20177:03 amRNSAppendix 4G
29th Sep 20177:01 amRNSAnnual Report and Annual Financial Statements
31st Aug 20177:10 amRNSWolf Gets Additional £5m,Tungsten Market Improves
21st Aug 20177:04 amRNSCancellation of Lapsed Performance Rights
17th Aug 20177:00 amRNSOperational Update
28th Jul 20177:00 amRNSAppendix 5B
28th Jul 20177:00 amRNSQuarterly Activities Report
3rd Jul 20174:09 pmRNSReplacement: Change of Directors' Interests
30th Jun 20177:03 amRNSDirector/PDMR Shareholding
30th Jun 20177:03 amRNSDirector/PDMR Shareholding
30th Jun 20177:03 amRNSDirector/PDMR Shareholding
30th Jun 20177:02 amRNSDirector/PDMR Shareholding
30th Jun 20177:02 amRNSCleansing Notice Letter
30th Jun 20177:02 amRNSAppendix 3B

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.